Britain’s FTSE 100 (.FTSE) index is seen opening 16 points lower at 6,584 on Friday.
Sanofi/GSK: An experimental COVID-19 vaccine of Sanofi (SASY.PA) and Britain’s GlaxoSmithKline (GSK.L) showed an insufficient immune response in clinical trial results, the French drugmaker said, a blow to efforts to find ways to fight the pandemic.
Banks: British banks can resume paying some dividends and bonuses after the Bank of England said they appeared well capitalised and resilient to any further coronavirus crisis fall-out.
Retail: With prospects for a post-Brexit trade deal with the EU looking precarious, Britain’s retail industry repeated a warning that shoppers faced higher food prices from next year if new tariffs were imposed in the absence of an agreement.
Gold: Gold edged up as the dollar held near a two-and-a-half-year low, offsetting concerns over delays in a U.S. coronavirus package.
Oil: Oil rose, extending a sharp rally overnight that saw Brent rise above $50 for the first time since March, as coronavirus vaccination rollouts kept hopes alive that demand for crude would build up next year.
The UK blue-chip index (.FTSE) closed 0.5% higher on Thursday as oil prices jumped to $50 per barrel for the first time since March on vaccine optimism and as a weaker British pound supported the export-heavy index GBP/.